Inhibition of bovine leukemia virus release by antiviral antibodies
- PMID: 200199
- DOI: 10.1007/BF01314487
Inhibition of bovine leukemia virus release by antiviral antibodies
Abstract
Peripheral blood lymphocytes from bovine leukemia virus (BLV) infected cattle were grown in vitro with serums from BLV-infected and uninfected cattle, sheep and rabbits. Only serums from infected animals which had antibody to gp 45/55, the major glycoprotein antigen, inhibited the release of virus from the cells. Although viral antigens could be detected in the cells themselves, none were detected in the supernatants of cultures grown with these serums. Normal serums and serums with antibody only to p23, the internal BLV antigen, did not inhibit virus release. To identify the factor responsible for virus release inhibition, 2 inhibitory serums were absorbed with either gp 44/55, p23 or tissue culture cells from BLV-infected and uninfected cells lines. The results indicated that antibody to gp 45/55 is the factor responsible for virus release inhibition.
Similar articles
-
Location of antigens associated with bovine leukemia virus.Arch Virol. 1977;55(1-2):131-7. doi: 10.1007/BF01314486. Arch Virol. 1977. PMID: 200198
-
Cytotoxic antibody in cattle and sheep exposed to bovine leukemia virus.Arch Virol. 1980;66(4):293-9. doi: 10.1007/BF01320625. Arch Virol. 1980. PMID: 6255901
-
[Comparative studies of sera from cattle with complete leukemia virus and glycoprotein antigens].Vet Med Nauki. 1980;17(1):58-63. Vet Med Nauki. 1980. PMID: 6251597 Bulgarian.
-
Detection of complement-dependent lytic antibodies in sera from bovine leukemia virus-infected animals.Ann Rech Vet. 1978;9(4):667-74. Ann Rech Vet. 1978. PMID: 224763
-
[Demonstration of the expression of bovine leukemogenic virus (BLV) in sheep lymphocytes by an immunofluorescence technic using monoclonal antibodies].Comp Immunol Microbiol Infect Dis. 1986;9(4):317-23. doi: 10.1016/0147-9571(86)90044-5. Comp Immunol Microbiol Infect Dis. 1986. PMID: 3026722 French.
Cited by
-
Antiviral Functions of Monoclonal Antibodies against Chikungunya Virus.Viruses. 2019 Mar 28;11(4):305. doi: 10.3390/v11040305. Viruses. 2019. PMID: 30925717 Free PMC article. Review.
-
Antibody bivalency improves antiviral efficacy by inhibiting virion release independently of Fc gamma receptors.Cell Rep. 2022 Feb 1;38(5):110303. doi: 10.1016/j.celrep.2022.110303. Cell Rep. 2022. PMID: 35108544 Free PMC article.
-
Inhibition of Marburg virus budding by nonneutralizing antibodies to the envelope glycoprotein.J Virol. 2012 Dec;86(24):13467-74. doi: 10.1128/JVI.01896-12. Epub 2012 Oct 3. J Virol. 2012. PMID: 23035224 Free PMC article.
-
Antibody-induced modulation of Friend virus cell surface antigens decreases virus production by persistent erythroleukemia cells: influence of the Rfv-3 gene.Proc Natl Acad Sci U S A. 1979 Nov;76(11):5784-8. doi: 10.1073/pnas.76.11.5784. Proc Natl Acad Sci U S A. 1979. PMID: 293683 Free PMC article.
-
Neutralizing Monoclonal Antibodies Block Chikungunya Virus Entry and Release by Targeting an Epitope Critical to Viral Pathogenesis.Cell Rep. 2015 Dec 22;13(11):2553-2564. doi: 10.1016/j.celrep.2015.11.043. Epub 2015 Dec 10. Cell Rep. 2015. PMID: 26686638 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources